Abstract O214 – Table 1. Virological primary outcomes

	Without M184V/I, N = 1489 (%)	With M184 V/I, N = 137 (%)
Virological failure (VF)	17 (1.14)	4 (3)
a) 1st definition: 2x HIV‐RNA >50 copies/mL	10 (0.67)	1 (0.73)
b) 2nd definition: 1x HIV‐RNA >50 copies/mL + ABC/3TC/DTG stop	7 (0.47)	3 (2.1)
Treatment (ABC/3TC/DTG) discontinued for reasons other than VF	232 (15.58)	14 (10.22)
Virological blipsa (VB) had at least one blip during ABC/3TC/DTG	63 (4.2)	12 (8.8)
VB, median copies/mL (IQR)	79 (62 to 122)	72 (58 to 154)
VF incidence (per 1000 person‐years)	13.56 (8.43 to 21.83)	29.8 (11.17 to 79.39)

^avirological blips: any viral load measurement >50 copies/mL, with viral load subsequently undetectable.